Table 1.
Patient Characteristics | Statistics |
---|---|
Male | 279 (66.4%) |
Age (years) | 62 ± 13 |
Current/ex smoker | 234 (55.7%) |
Existing medical conditions | |
History of malignancy | 135 (32.1%) |
Chronic kidney disease | 32 (7.6%) |
Chronic liver disease | 6 (1.4%) |
Ischemic heart disease | 61 (14.5%) |
Elevated creatinine (>90 μmol/L) | 69 (16.4%) |
Thrombocytopenia (<100 × 109/L) | 4 (1%) |
Body Mass Index (BMI) | |
Underweight BMI < 18.5 | 32 (7.6%) |
Overweight BMI 25–30 | 85 (20.2) |
Obese BMI > 30 | 32 (7.6%) |
Coagulopathy | |
PT > 14 | |
APTT > 35 | |
Antiplatelet/Anticoagulation use | 56 (13.3%) |
Aspirin | 54 (12.9%) |
Clopidogrel | |
Ticagrelor | 69 (16.4%) |
Warfarin | 22 (5.2%) |
Heparin | 1 (0.2%) |
Rivaroxaban | 5 (1.2%) |
Ticlopidine | 3 (0.7%) |
Aspirin + clopidogrel | 1 (0.2%) |
Aspirin + ticagrelor | 1 (0.2%) |
Aspirin + dabigatran | 6 (1.4%) |
1 (0.2%) | |
1 (0.2%) |